Specialty Pharmacy Per-fill Fee Rejected by OIG

by Baker Ober Health Law

This article originally appeared as a Fraud and Abuse Practice Group Email Alert by the American Health Lawyers Association. Copyright 2014, American Health Lawyers Association, Washington DC. Reprint permission granted.

On August 15, 2014, the U.S. Department of Health & Human Services, Office of Inspector General (OIG) issued a “negative” opinion regarding a specialty pharmacy’s proposal to pay a per-fill fee to local pharmacies for support services they provide in connection with patient referrals to the specialty pharmacy. Finding that the per-fill fee could materially influence the local pharmacies’ referral decisions, the OIG concluded that the proposed arrangement implicated the antikickback statute and posed more than a minimal risk of fraud and abuse.

The Requestor of the advisory opinion is a specialty pharmacy that dispenses specialty drugs used to treat a variety of chronic and life-threatening diseases, including cancer, HIV/AIDs, multiple sclerosis and hemophilia (Requestor). According to the Requestor, the specialty drugs may be unavailable at local retail pharmacies for various reasons, including, for example, manufacturers limit their distribution networks to a small number of pharmacies, payors designate specific dispensing pharmacies for specialty drugs, and/or specialty drugs require special handling or inventory management services.

The Requestor asked the OIG whether it would be permissible to enter into agreements with various local pharmacies and pharmacy networks pursuant to which the Requestor would provide specialty drugs to their patients. In exchange for a per-fill fee amount, the local pharmacy would be required to provide various support services, including: (1) accepting the prescription from the patient or prescriber; (2) gathering patient and prescriber demographic information; (3) recording patient-specific medication history and use, including drug names, strength and directions; (4) patient counseling; (5) informing the patients about access to specialty drugs, including the availability from pharmacies other than the Requestor’s pharmacy; (6) obtaining patient consent to forward the prescription to the Requestor; (7) transferring prescription information to the Requestor; and (8) providing ongoing patient assessments for subsequent refills. The Requestor certified that the per-fill fee, which is paid upon the receipt of the initial prescription and each subsequent refill, is fair market value for the support services.

The OIG concluded that the antikickback statute was implicated by the proposed arrangement because the Requestor would pay a per-fill fee for support services each time a local pharmacy referred a specialty drug prescription to the Requestor. In its analysis, the OIG noted that the Requestor paid the local pharmacy for support services only if the services result in a referral to the Requestor. Thus, the OIG found that such per-fill fee is “directly linked” to business generated by the local pharmacy for the Requestor, and could materially influence the local pharmacy’s referral decisions. While the OIG recognized that the local pharmacy’s support services may benefit the patient in terms of care coordination, the OIG noted that the antikickback statute is implicated if one purpose of the remuneration is to generate referrals. The OIG stated that there is “significant” risk that the per-fill fees are compensation to the local pharmacy for generating referrals, rather than solely compensation for bona fide, commercially reasonable services.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Baker Ober Health Law | Attorney Advertising

Written by:

Baker Ober Health Law

Baker Ober Health Law on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.